Molecular biomarkers for autoimmune retinopathies: Significance of anti-transducin-alpha autoantibodies
- 31 December 2009
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 87 (3) , 195-203
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathyJournal of Autoimmunity, 2009
- Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathyAutoimmunity Reviews, 2009
- Fifteen-Year Follow-Up of Patient with Cancer-Associated RetinopathyJapanese Journal of Ophthalmology, 2007
- Photoreceptor proteins as cancer‐retina antigensInternational Journal of Cancer, 2006
- Cancer Associated Retinopathy (CAR): An Autoimmune-Mediated Paraneoplastic SyndromeSeminars in Ophthalmology, 2006
- Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumorsLung Cancer, 2004
- Constitutive opsin signaling: night blindness or retinal degeneration?Trends in Molecular Medicine, 2004
- Paraneoplastic disorders of neuro-ophthalmologic interestCurrent Opinion in Ophthalmology, 1996
- Missense mutation in the gene encoding the α subunit of rod transducin in the Nougaret form of congenital stationary night blindnessNature Genetics, 1996
- The Occurrence of Serum Autoantibodies against Enolase in Cancer-Associated RetinopathyClinical Immunology and Immunopathology, 1996